{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:59:56Z","timestamp":1785729596395,"version":"3.56.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014751","name":"Neuraxpharm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-06520-3","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:32:23Z","timestamp":1769553143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recommendations for the community-based management of prolonged convulsive seizures in children in Europe"],"prefix":"10.1186","volume":"26","author":[{"given":"Federico","family":"Vigevano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Arzimanoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Auvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Kaindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mazurkiewicz-Be\u0142dzi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Pujar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Smeyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Helen","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"6520_CR1","unstructured":"Epilepsy Society. List of anti-seizure medication. https:\/\/epilepsysociety.org.uk\/about-epilepsy\/anti-seizure-medication\/list-anti-seizure-medication. Accessed 10 Oct 2024."},{"key":"6520_CR2","unstructured":"Spanish Agency of Medicines and Medical Devices. [Use of antiseizure medications in Spain]. 2023 https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/observatorio-de-uso-de-medicamentos\/informes\/. Accessed 10 Oct 2024."},{"key":"6520_CR3","first-page":"441","volume":"1","author":"A Gabald\u00f3n","year":"2022","unstructured":"Gabald\u00f3n A, Nieto J. Smeyers P [Refractory epilepsies]. Protoc Diagn Ter Pediatr. 2022;1:441\u20138.","journal-title":"Protoc Diagn Ter Pediatr"},{"key":"6520_CR4","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus\u2013report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515\u201323.","journal-title":"Epilepsia"},{"key":"6520_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/jcm8010039","volume":"8","author":"C Minardi","year":"2019","unstructured":"Minardi C, Minacapelli R, Valastro P, Vasile F, Pitino S, Pavone P, et al. Epilepsy in children: from diagnosis to treatment with focus on emergency. J Clin Med. 2019;8:39.","journal-title":"J Clin Med"},{"key":"6520_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/archdischild-2021-323351","volume":"108","author":"M Bacon","year":"2023","unstructured":"Bacon M, Appleton R, Bangalore H, Brand C, Browning J, Chin RFM, et al. Review of the new APLS guideline (2022): Management of the convulsing child. Arch Dis Child Educ Pract Ed. 2023;108:43\u20138.","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"6520_CR7","doi-asserted-by":"publisher","first-page":"10866","DOI":"10.1038\/s41598-022-15115-8","volume":"12","author":"KE Fuest","year":"2022","unstructured":"Fuest KE, Hofberger C, Lorenz M, Ulm B, Kanz KG, Blobner M, et al. Excessive hospitalization of patients with seizures in the Germany prehospital emergency system: a retrospective cohort study. Sci Rep. 2022;12:10866.","journal-title":"Sci Rep"},{"key":"6520_CR8","doi-asserted-by":"publisher","first-page":"108264","DOI":"10.1016\/j.yebeh.2021.108264","volume":"123","author":"P Penovich","year":"2021","unstructured":"Penovich P, Glauser T, Becker D, Patel AD, Sirven J, Long L, et al. Recommendations for development of acute seizure action plans (ASAPs) from an expert panel. Epilepsy Behav. 2021;123:108264.","journal-title":"Epilepsy Behav"},{"issue":"Spec No 1","key":"6520_CR9","first-page":"S2","volume":"16","author":"JH Cross","year":"2014","unstructured":"Cross JH. Setting the scene: definition of prolonged seizures, acute repetitive seizures, and status epilepticus. Do we know why seizures stop? Epileptic Disord. 2014;16(Spec No 1):S2-5.","journal-title":"Epileptic Disord"},{"key":"6520_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yebeh.2015.03.023","volume":"49","author":"J Dobesberger","year":"2015","unstructured":"Dobesberger J, Risti\u0107 AJ, Walser G, Kuchukhidze G, Unterberger I, H\u00f6fler J, et al. Duration of focal complex, secondarily generalized tonic-clonic, and primarily generalized tonic-clonic seizures\u2013a video-EEG analysis. Epilepsy Behav. 2015;49:111\u20137.","journal-title":"Epilepsy Behav"},{"key":"6520_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","volume":"368","author":"RF Chin","year":"2006","unstructured":"Chin RF, Neville BG, Peckham C, Bedford H, Wade A, Scott RC. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368:222\u20139.","journal-title":"Lancet"},{"key":"6520_CR12","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/j.1528-1167.2007.01175.x","volume":"48","author":"M Raspall-Chaure","year":"2007","unstructured":"Raspall-Chaure M, Chin RFM, Neville BG, Bedford H, Scott RC. The epidemiology of convulsive status epilepticus in children: a critical review. Epilepsia. 2007;48:1652\u201363.","journal-title":"Epilepsia"},{"key":"6520_CR13","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/dmcn.14900","volume":"63","author":"C Mitchell","year":"2021","unstructured":"Mitchell C, Chatterton Dickson L, Ramsay A, Mesalles-Naranjo O, Leonard P, Brand C, et al. Epidemiology and outcome of status epilepticus in children: a Scottish population cohort study. Dev Med Child Neurol. 2021;63:1075\u201384.","journal-title":"Dev Med Child Neurol"},{"key":"6520_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejpn.2017.07.017","volume":"22","author":"F Vigevano","year":"2018","unstructured":"Vigevano F, Kirkham FJ, Wilken B, Raspall-Chaure M, Grebla R, Lee D, et al. Effect of rescue medication on seizure duration in non-institutionalized children with epilepsy. Eur J Paediatr Neurol. 2018;22:56\u201363.","journal-title":"Eur J Paediatr Neurol"},{"key":"6520_CR15","first-page":"S1","volume":"16 Spec No","author":"A Arzimanoglou","year":"2014","unstructured":"Arzimanoglou A, Lagae L. Understanding the mechanisms, identifying and treating prolonged epileptic seizures. Epileptic Disord. 2014;16 Spec No:S1.","journal-title":"Epileptic Disord."},{"key":"6520_CR16","doi-asserted-by":"publisher","first-page":"107836","DOI":"10.1016\/j.yebeh.2021.107836","volume":"117","author":"J Buchhalter","year":"2021","unstructured":"Buchhalter J, Shafer PO, Buelow JM, French JA, Gilchrist B, Hirsch LJ, et al. Preferred practices for rescue treatment of seizure clusters: a consensus-driven, multi-stakeholder approach. Epilepsy Behav. 2021;117:107836.","journal-title":"Epilepsy Behav"},{"key":"6520_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40263-023-01060-1","volume":"38","author":"PE Penovich","year":"2024","unstructured":"Penovich PE, Rao VR, Long L, Carrazana E, Rabinowicz AL. Benzodiazepines for the Treatment of Seizure Clusters. CNS Drugs. 2024;38:125\u201340.","journal-title":"CNS Drugs"},{"key":"6520_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","volume":"44","author":"E Trinka","year":"2017","unstructured":"Trinka E, K\u00e4lvi\u00e4inen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017;44:65\u201373.","journal-title":"Seizure"},{"key":"6520_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.anpedi.2013.09.011","volume":"81","author":"M Raspall-Chaure","year":"2014","unstructured":"Raspall-Chaure M, Mart\u00ednez-Bermejo A, Pantoja-Mart\u00ednez J, Paredes-Carmona F, S\u00e1nchez-Carpintero R. Wait S [Management of prolonged convulsive seizures in the community: results of the PERFECTTM study in Spain]. An Pediatr. 2014;81:99\u2013106.","journal-title":"An Pediatr"},{"key":"6520_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2147\/OAEM.S293258","volume":"14","author":"S Messahel","year":"2022","unstructured":"Messahel S, Bracken L, Appleton R. Optimal management of status epilepticus in children in the emergency setting: a review of recent advances. Open Access Emerg Med. 2022;14:491\u2013506.","journal-title":"Open Access Emerg Med"},{"key":"6520_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0031-3955(05)70334-5","volume":"48","author":"UA Hanhan","year":"2001","unstructured":"Hanhan UA, Fiallos MR, Orlowski JP. Status epilepticus. Pediatr Clin North Am. 2001;48:683\u201394.","journal-title":"Pediatr Clin North Am"},{"key":"6520_CR22","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1684\/epd.2014.0689","volume":"16","author":"RC Scott","year":"2014","unstructured":"Scott RC. What are the effects of prolonged seizures in the brain? Epileptic Disord. 2014;16:S6.","journal-title":"Epileptic Disord"},{"key":"6520_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1474-4422(06)70546-4","volume":"5","author":"M Raspall-Chaure","year":"2006","unstructured":"Raspall-Chaure M, Chin RF, Neville BG, Scott RC. Outcome of paediatric convulsive status epilepticus: a systematic review. Lancet Neurol. 2006;5:769\u201379.","journal-title":"Lancet Neurol"},{"key":"6520_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/epi.14515","volume":"59","author":"C Sculier","year":"2018","unstructured":"Sculier C, Ga\u00ednza-Lein M, S\u00e1nchez Fern\u00e1ndez I, Loddenkemper T. Long-term outcomes of status epilepticus: a critical assessment. Epilepsia. 2018;59:155\u201369.","journal-title":"Epilepsia"},{"key":"6520_CR25","doi-asserted-by":"publisher","first-page":"100409","DOI":"10.1016\/j.ebr.2020.100409","volume":"15","author":"A Asnis-Alibozek","year":"2021","unstructured":"Asnis-Alibozek A, Detyniecki K. The unmet need for rapid epileptic seizure termination (REST). Epilepsy Behav Rep. 2021;15:100409.","journal-title":"Epilepsy Behav Rep"},{"key":"6520_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2018.05.021","volume":"68","author":"M Ga\u00ednza-Lein","year":"2019","unstructured":"Ga\u00ednza-Lein M, Fern\u00e1ndez IS, Ulate-Campos A, Loddenkemper T, Ostendorf AP. Timing in the treatment of status epilepticus: From basics to the clinic. Seizure. 2019;68:22\u201330.","journal-title":"Seizure"},{"key":"6520_CR27","first-page":"S89","volume":"16 Spec No","author":"BA Neubauer","year":"2014","unstructured":"Neubauer BA, Hahn A. Syndromes at risk of status epilepticus in children: genetic and pathophysiological issues. Epileptic Disord. 2014;16 Spec No:S89-95.","journal-title":"Epileptic Disord."},{"key":"6520_CR28","doi-asserted-by":"publisher","first-page":"14S","DOI":"10.1177\/0883073807303065","volume":"22","author":"S Shinnar","year":"2007","unstructured":"Shinnar S. Who is at risk for prolonged seizures? J Child Neurol. 2007;22:14S-20S.","journal-title":"J Child Neurol"},{"key":"6520_CR29","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1017\/CBO9780511921001.107","volume-title":"Causes Epilepsy Common Uncommon Causes Adults Child","author":"RC Scott","year":"2011","unstructured":"Scott RC. Causes of status epilepticus in children. In: Shorvon SD, Andermann F, Guerrini R, editors. Causes Epilepsy Common Uncommon Causes Adults Child. Cambridge, UK: Cambridge University Press; 2011. p. 730\u20134."},{"key":"6520_CR30","first-page":"S96","volume":"16 Spec No","author":"T Bast","year":"2014","unstructured":"Bast T. Syndromes with very low risk of acute prolonged seizures. Epileptic Disord. 2014;16 Spec No:S96-102.","journal-title":"Epileptic Disord."},{"key":"6520_CR31","first-page":"3","volume-title":"Pellock\u2019s Pediatr Epilepsy","author":"S Auvin","year":"2017","unstructured":"Auvin S. Chapter 1: Pathophysiology of Seizures in the Developing Brain. In: Pellock JM, Nordli DRJ, Sankar R, Wheless JW, editors. Pellock\u2019s Pediatr Epilepsy. New York, NY: Springer Publishing Company; 2017. p. 3\u201319."},{"key":"6520_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11940-016-0401-x","volume":"18","author":"JG Ochoa","year":"2016","unstructured":"Ochoa JG, Kilgo WA. The role of benzodiazepines in the treatment of epilepsy. Curr Treat Options Neurol. 2016;18:1\u201311.","journal-title":"Curr Treat Options Neurol"},{"key":"6520_CR33","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","volume":"36","author":"R Kienitz","year":"2022","unstructured":"Kienitz R, Kay L, Beuchat I, Gelhard S, von Brauchitsch S, Mann C, et al. Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability. CNS Drugs. 2022;36:951\u201375.","journal-title":"CNS Drugs"},{"key":"6520_CR34","unstructured":"Electronic Medicines Compendium (EMC). Diazepam Desitin 5 mg Rectal solution - Summary of Product Characteristics (SmPC). https:\/\/www.medicines.org.uk\/emc\/product\/2997\/smpc#gref. Accessed 18 March 2025."},{"key":"6520_CR35","unstructured":"European Medicines Agency. Buccolam: Summary of product characteristics. https:\/\/www.ema.europa.eu\/documents\/product-information\/buccolam-epar-product-information_en.pdf. Accessed 2 May 2024."},{"key":"6520_CR36","unstructured":"IQVIA MIDAS\u00ae Quarterly Audit from Q3\/2013 to Q2\/2025; data extracted: November 2025. https:\/\/www.iqvia.com\/solutions\/commercialization\/data-and-information-management\/midas. Accessed 28 Nov 2025."},{"key":"6520_CR37","unstructured":"European Medicines Agency. Nasolam and associated names. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/nasolam-associated-names. Accessed 10 Feb 2025."},{"key":"6520_CR38","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3390\/jcm10081754","volume":"10","author":"S Almohaish","year":"2021","unstructured":"Almohaish S, Sandler M, Brophy GM. Time is brain: acute control of repetitive seizures and status epilepticus using alternative routes of administration of benzodiazepines. J Clin Med. 2021;10:1754.","journal-title":"J Clin Med"},{"key":"6520_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/PPA.S39233","volume":"7","author":"M Anderson","year":"2013","unstructured":"Anderson M. Buccal midazolam for pediatric convulsive seizures: efficacy, safety, and patient acceptability. Patient Prefer Adherence. 2013;7:27.","journal-title":"Patient Prefer Adherence"},{"key":"6520_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2165\/11209320-000000000-00000","volume":"14","author":"KP Garnock-Jones","year":"2012","unstructured":"Garnock-Jones KP. Oromucosal midazolam: a review of its use in pediatric patients with prolonged acute convulsive seizures. Pediatr Drugs. 2012;14:251\u201361.","journal-title":"Pediatr Drugs"},{"key":"6520_CR41","unstructured":"Spanish Agency of Medicine and Sanitary Products. Stesolid: [Summary of product characteristics]. https:\/\/cima.aemps.es\/cima\/pdfs\/es\/ft\/58000\/FT_58000.html.pdf. Accessed 18 March 2025."},{"key":"6520_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0140-6736(98)06425-3","volume":"353","author":"RC Scott","year":"1999","unstructured":"Scott RC, Besag FMC, Neville BGR. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353:623\u20136.","journal-title":"Lancet"},{"key":"6520_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","volume":"366","author":"J McIntyre","year":"2005","unstructured":"McIntyre J, Robertson S, Norris E, Appleton R, Whitehouse WP, Phillips B, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366:205\u201310.","journal-title":"Lancet"},{"key":"6520_CR44","doi-asserted-by":"publisher","first-page":"107391","DOI":"10.1016\/j.yebeh.2020.107391","volume":"112","author":"B Gidal","year":"2020","unstructured":"Gidal B, Klein P, Hirsch LJ. Seizure clusters, rescue treatments, seizure action plans: unmet needs and emerging formulations. Epilepsy Behav. 2020;112:107391.","journal-title":"Epilepsy Behav"},{"issue":"Suppl 1","key":"6520_CR45","first-page":"S34","volume":"63","author":"B Gidal","year":"2022","unstructured":"Gidal B, Detyniecki K. Rescue therapies for seizure clusters: pharmacology and target of treatments. Epilepsia. 2022;63(Suppl 1):S34-44.","journal-title":"Epilepsia"},{"key":"6520_CR46","first-page":"335","volume-title":"Mod Anesth Handb Exp Pharmacol","author":"KT Olkkola","year":"2008","unstructured":"Olkkola KT, Ahonen J. Midazolam and other benzodiazepines. In: Sch\u00fcttler J, Schwilden H, editors. Mod Anesth Handb Exp Pharmacol. Berlin, Heidelberg: Springer; 2008. p. 335\u201360."},{"key":"6520_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1553-2712.2010.00751.x","volume":"17","author":"J McMullan","year":"2010","unstructured":"McMullan J, Sasson C, Pancioli A, Silbergleit R. Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med. 2010;17:575\u201382.","journal-title":"Acad Emerg Med"},{"key":"6520_CR48","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1177\/0883073809332768","volume":"24","author":"K Sofou","year":"2009","unstructured":"Sofou K, Kristj\u00e1nsd\u00f3ttir R, Papachatzakis NE, Ahmadzadeh A, Uvebrant P. Management of prolonged seizures and status epilepticus in childhood: a systematic review. J Child Neurol. 2009;24:918\u201326.","journal-title":"J Child Neurol"},{"key":"6520_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/adc.2002.019836","volume":"89","author":"MT Wilson","year":"2004","unstructured":"Wilson MT, Macleod S, O\u2019Regan ME. Nasal\/buccal midazolam use in the community. Arch Dis Child. 2004;89:50\u20131.","journal-title":"Arch Dis Child"},{"key":"6520_CR50","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/000992280504400904","volume":"44","author":"\u015e Baysun","year":"2005","unstructured":"Baysun \u015e, Aydin \u00d6F, Atmaca E, YavuzG\u00fcrer YK. A comparison of buccal midazolam and rectal diazepam for the acute treatment of seizures. Clin Pediatr (Phila). 2005;44:771\u20136.","journal-title":"Clin Pediatr (Phila)"},{"key":"6520_CR51","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1097\/PEC.0000000000001114","volume":"35","author":"R Moretti","year":"2019","unstructured":"Moretti R, Julliand S, Rinaldi VE, Titomanlio L. Buccal Midazolam Compared With Rectal Diazepam Reduces Seizure Duration in Children in the Outpatient Setting. Pediatr Emerg Care. 2019;35:760\u20134.","journal-title":"Pediatr Emerg Care"},{"key":"6520_CR52","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.braindev.2008.11.006","volume":"31","author":"B Talukdar","year":"2009","unstructured":"Talukdar B, Chakrabarty B. Efficacy of buccal midazolam compared to intravenous diazepam in controlling convulsions in children: a randomized controlled trial. Brain Dev. 2009;31:744\u20139.","journal-title":"Brain Dev"},{"key":"6520_CR53","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ejpn.2010.05.009","volume":"14","author":"MR Ashrafi","year":"2010","unstructured":"Ashrafi MR, Khosroshahi N, Karimi P, Malamiri RA, Bavarian B, Zarch AV, et al. Efficacy and usability of buccal midazolam in controlling acute prolonged convulsive seizures in children. Eur J Paediatr Neurol. 2010;14:434\u20138.","journal-title":"Eur J Paediatr Neurol"},{"key":"6520_CR54","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1542\/peds.2007-0930","volume":"121","author":"A Mpimbaza","year":"2008","unstructured":"Mpimbaza A, Ndeezi G, Staedke S, Rosenthal PJ, Byarugaba J. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial. Pediatrics. 2008;121:e58-64.","journal-title":"Pediatrics"},{"key":"6520_CR55","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1111\/apa.12529","volume":"103","author":"A Khan","year":"2014","unstructured":"Khan A, Baheerathan A, Setty G, Hussain N. Carers\u2019 express positive views on the acceptability, efficacy and safety of buccal midazolam for paediatric status epilepticus. Acta Paediatr. 2014;103:e165\u20138.","journal-title":"Acta Paediatr"},{"key":"6520_CR56","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s40263-015-0271-x","volume":"29","author":"F Brigo","year":"2015","unstructured":"Brigo F, Nardone R, Tezzon F, Trinka E. A common reference-based indirect comparison meta-analysis of buccal versus intranasal midazolam for early status epilepticus. CNS Drugs. 2015;29:741\u201357.","journal-title":"CNS Drugs"},{"key":"6520_CR57","doi-asserted-by":"publisher","first-page":"1175370","DOI":"10.3389\/fneur.2023.1175370","volume":"14","author":"LL Becker","year":"2023","unstructured":"Becker LL, Gratopp A, Prager C, Elger CE, Kaindl AM. Treatment of pediatric convulsive status epilepticus. Front Neurol. 2023;14:1175370.","journal-title":"Front Neurol"},{"key":"6520_CR58","unstructured":"Epilepsies in children, young people and adults. National Institute for Health and Care Excellence (NICE) guideline [NG217]. NICE; 2022. https:\/\/www.nice.org.uk\/guidance\/ng217. Accessed 15 Sep 2024."},{"key":"6520_CR59","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s13760-013-0247-x","volume":"113","author":"L De Waele","year":"2013","unstructured":"De Waele L, Boon P, Ceulemans B, Dan B, Jansen A, Legros B, et al. First line management of prolonged convulsive seizures in children and adults: good practice points. Acta Neurol Belg. 2013;113:375\u201380.","journal-title":"Acta Neurol Belg"},{"key":"6520_CR60","unstructured":"L\u00f3pez Gonz\u00e1lez FJ, Villanueva Haba V, Falip Centelles M, Toledo Argany M, Campos Blanco D, Serratosa Fern\u00e1ndez J, editors. Manual de Pr\u00e1ctica Cl\u00ednica en Epilepsia. Recomendaciones diagn\u00f3stico-terap\u00e9uticas de la SEN 2019. Madrid, Spain: Sociedad Espa\u00f1ola de Neurolog\u00eda; 2019."},{"key":"6520_CR61","unstructured":"National klinisk retningslinje for udredning og behandling af epilepsi hos b\u00f8rn og unge. 2017. https:\/\/www.sst.dk\/da\/udgivelser\/2015\/nkr-epilepsi-hos-boern-og-unge. Accessed 18 March 2025."},{"key":"6520_CR62","first-page":"445","volume":"31","author":"S Bourguignon","year":"2014","unstructured":"Bourguignon S, Marque S, Auvin S, Titomanlio L. Prise en charge des crises \u00e9pileptiques chez l\u2019enfant\u202f: une analyse d\u2019impact budg\u00e9taire. J Gest d\u2019Economie Medicales. 2014;31:445\u201356.","journal-title":"J Gest d\u2019Economie Medicales"},{"key":"6520_CR63","unstructured":"Prise en charge des \u00e9tats de mal \u00e9pileptiques en pr\u00e9hospitalier, en structure d\u2019urgence et en r\u00e9animation dans les 48 premi\u00e8res heures. 2018. https:\/\/www.srlf.org\/wp-content\/uploads\/2018\/06\/22062018_RFE-Etat-de-mal-\u00e9pileptique-SRLF-SFMU.pdf. Accessed 18 March 2025."},{"key":"6520_CR64","unstructured":"Scottish Medicines Consortium. Medicines Advice. Buccolam https:\/\/scottishmedicines.org.uk\/medicines-advice\/midazolam-buccolam-oromucosal-solution-fullsubmission-75712\/. Accessed 18 March 2025."},{"key":"6520_CR65","unstructured":"Behandling av status epilepticus hos barn. Verjson 1.5. 2023. https:\/\/metodebok.no\/index.php?action=topic&item=F7RNAdMw. Accessed 18 March 2025."},{"key":"6520_CR66","unstructured":"L\u00e4kemedel vid epilepsi \u2013 behandlings\u00adrekommendation | L\u00e4kemedelsverket. 2019 https:\/\/www.lakemedelsverket.se\/sv\/behandling-och-forskrivning\/behandlingsrekommendationer\/sok-behandlingsrekommendationer\/lakemedel-vid-epilepsi--behandlingsrekommendation. Accessed 28 Sep 2023 18 March 2025."},{"issue":"Suppl 7","key":"6520_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/epi.12307","volume":"54","author":"G Capovilla","year":"2013","unstructured":"Capovilla G, Beccaria F, Beghi E, Minicucci F, Sartori S, Vecchi M. Treatment of convulsive status epilepticus in childhood: recommendations of the Italian League Against Epilepsy. Epilepsia. 2013;54(Suppl 7):23\u201334.","journal-title":"Epilepsia"},{"key":"6520_CR68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejpn.2012.07.002","volume":"17","author":"S Wait","year":"2013","unstructured":"Wait S, Lagae L, Arzimanoglou A, Beghi E, Bennett C, Cross JH, et al. The administration of rescue medication to children with prolonged acute convulsive seizures in the community: What happens in practice? Eur J Paediatr Neurol. 2013;17:14\u201323.","journal-title":"Eur J Paediatr Neurol"},{"key":"6520_CR69","unstructured":"Allonneau-Roubertie E, Auvin S, Bast T, Enza Cervellione RA, Covanis A, Corliss R, et al. Ensuring appropriate management of prolonged convulsive seizures in children with epilepsy outside of hospital. A policy paper to ensure a safe and inclusive education for at-risk children. 2017. https:\/\/www.healthpolicypartnership.com\/wp-content\/uploads\/CE_policy_paper.pdf. Accessed 10 Feb 2025."},{"key":"6520_CR70","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.15190\/d.2020.7","volume":"8","author":"H Anwar","year":"2020","unstructured":"Anwar H, Khan QU, Nadeem N, Pervaiz I, Ali M, Cheema FF. Epileptic seizures. Discoveries (Craiova). 2020;8:e128.","journal-title":"Discoveries (Craiova)"},{"key":"6520_CR71","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrneurol.2011.24","volume":"7","author":"O Devinsky","year":"2011","unstructured":"Devinsky O, Gazzola D, Lafrance WC. Differentiating between nonepileptic and epileptic seizures. Nat Rev Neurol. 2011;7:210\u201320.","journal-title":"Nat Rev Neurol"},{"key":"6520_CR72","unstructured":"First aid - Epilepsy Action. https:\/\/www.epilepsy.org.uk\/info\/first-aid. Accessed 3 Jun 2024."},{"key":"6520_CR73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yebeh.2018.08.010","volume":"87","author":"BT Tyson","year":"2018","unstructured":"Tyson BT, Baker S, Greenacre M, Kent KJ, Lichtenstein JD, Sabelli A, et al. Differentiating epilepsy from psychogenic nonepileptic seizures using neuropsychological test data. Epilepsy Behav. 2018;87:39\u201345.","journal-title":"Epilepsy Behav"},{"key":"6520_CR74","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/epi4.12569","volume":"7","author":"E Cardenal-Mu\u00f1oz","year":"2022","unstructured":"Cardenal-Mu\u00f1oz E, Auvin S, Villanueva V, Cross JH, Zuberi SM, Lagae L, et al. Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe. Epilepsia Open. 2022;7:11.","journal-title":"Epilepsia Open"},{"key":"6520_CR75","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/14737175.2024.2305813","volume":"24","author":"R Roberti","year":"2024","unstructured":"Roberti R, Riva A, D\u2019Onofrio G, Giacheri E, Amadori E, Vari MS, et al. A proposal for a shared therapeutic algorithm in children with prolonged convulsive seizures and status epilepticus. Expert Rev Neurother. 2024;24:133\u20138.","journal-title":"Expert Rev Neurother"},{"key":"6520_CR76","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jamda.2023.04.015","volume":"24","author":"RE Ramsay","year":"2023","unstructured":"Ramsay RE, Becker DA, Vazquez B, Birnbaum AK, Misra SN, Carrazana E, et al. Acute Abortive Therapies for Seizure Clusters in Long-Term Care. J Am Med Dir Assoc. 2023;24:1225\u201332.","journal-title":"J Am Med Dir Assoc"},{"key":"6520_CR77","doi-asserted-by":"publisher","first-page":"106340","DOI":"10.1016\/j.yebeh.2019.04.058","volume":"102","author":"FJ Kirkham","year":"2020","unstructured":"Kirkham FJ, Vigevano F, Raspall-Chaure M, Wilken B, Lee D, Le Reun C, et al. Health-related quality of life and the burden of prolonged seizures in noninstitutionalized children with epilepsy. Epilepsy Behav. 2020;102:106340.","journal-title":"Epilepsy Behav"},{"key":"6520_CR78","unstructured":"Training courses. Young Epilepsy. https:\/\/www.youngepilepsy.org.uk\/professionals\/education-professionals\/training-courses. Accessed 13 Jul 2024."},{"key":"6520_CR79","doi-asserted-by":"publisher","first-page":"e0249681","DOI":"10.1371\/journal.pone.0249681","volume":"16","author":"LF Iannone","year":"2021","unstructured":"Iannone LF, Roberti R, Arena G, Mammone S, Pulitano P, de Sarro G, et al. Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: implications for inclusion and safety in the educational system. PLoS ONE. 2021;16:e0249681.","journal-title":"PLoS ONE"},{"key":"6520_CR80","unstructured":"Buccolam\u00ae: Administration Video - Neuraxpharm UK. https:\/\/www.neuraxpharm.com\/uk\/physician\/training-capsules\/buccolam-administration-video. Accessed 15 Oct 2024."},{"key":"6520_CR81","unstructured":"Anwendungsvideo Buccolam\u00ae - Neuraxpharm Deutsch. https:\/\/www.neuraxpharm.com\/de\/arzt\/ressourcen\/anwendungsvideo-buccolam. Accessed 15 Oct 2024."},{"key":"6520_CR82","unstructured":"Neuraxpharm Video Administration Buccolam - France \u2013 YouTube. https:\/\/www.youtube.com\/watch?v=gnMXvBCoP6A. Accessed 15 Oct 2024."},{"key":"6520_CR83","unstructured":"Video educativo somministrazione Buccolam \u2013 YouTube. https:\/\/www.youtube.com\/watch?v=BQ-8ZuDv3LM. Accessed 15 Oct 2024."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06520-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T04:12:29Z","timestamp":1774239149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06520-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6520"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06520-3","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The final version was updated as there were two images in Table 3 overlapping on the text.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors received consulting honoraria from Neuraxpharm (CEREBRO SPAIN BIDCO S.L.).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}